Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis
| Autor: | Bardsley, Samuel, Criner, Gerard J., Halpin, David M.G., Han, MeiLan K., Hanania, Nicola A., Hill, David, Lange, Peter, Lipson, David A., Martinez, Fernando J., Midwinter, Dawn, Siler, Thomas M., Singh, Dave, Wise, Robert A., van Zyl-Smit, Richard N., Berkman, Neville |
|---|---|
| Zdroj: | In Respiratory Medicine December 2022 205 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect